STAQ Pharma is a biotechnology and pharmaceutical startup focused on delivering safety, transparency, availability, and quality to outsourced medications. Founded in 2017, the company prioritizes safety by offering pediatric and adult concentrations developed with guidance from Children’s Hospital Colorado. Its commitment to transparency is evident through video feeds with remote access, proactive sharing of 483s and corrective actions, and final product testing on every batch to comply with FDA regulations. Additionally, the company ensures availability by onsite production of non-sterile to sterile solutions and sterile-to-sterile repackaging, along with an advanced inventory system that forecasts needs. With the capacity to produce up to 30,000 pre-filled syringes a day, STAQ Pharma, centrally located in Denver, Colorado and Columbus, Ohio, aims to address shortage issues and support hospitals across the United States. The startup utilizes advanced technology and an extensive Quality Management System to maintain high standards in the pharmaceutical industry. Its last investment, a Venture - Series Unknown investment, was secured on 12 September 2024.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture - Series Unknown | Unknown | - | 12 Sep 2024 | |
Venture - Series Unknown | Unknown | - | 28 Apr 2023 | |
Series C | Unknown | - | 02 Mar 2022 | |
Venture - Series Unknown | Unknown | - | 31 Mar 2021 | |
Venture - Series Unknown | Unknown | - | 03 May 2019 |
No recent news or press coverage available for STAQ Pharma.